Kaleido_rgb_300dpi.jpg
Kaleido Biosciences Announces Closing of Initial Public Offering
March 04, 2019 16:15 ET | Kaleido Biosciences
LEXINGTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the...
Kaleido_rgb_300dpi.jpg
Kaleido Biosciences Announces Pricing of Initial Public Offering
February 27, 2019 19:27 ET | Kaleido Biosciences
LEXINGTON, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the...